News about <![CDATA[Unassigned]]> News about en-us <![CDATA[PSivida: An Extremely Undervalued Ophthalmology Small Cap Investment With Upcoming Catalyst]]> <![CDATA[This Biotechnology Platform Could Save Millions of Lives: Patrick Cox]]> <![CDATA[Global Expansion and Affordable Care Act Boost Life Science Tools and Diagnostics: Bryan Brokmeier]]> <![CDATA[Japan Distracts Investors With Olympic Five-Ring Circus]]> <![CDATA[Despite Near-Term Troubles Eliquis’ Future Looks Bright]]> <![CDATA[Despite Near-Term Troubles Eliquis’ Future Looks Bright]]> <![CDATA[Why Roche’s Patent Problems In India Aren’t A Big Concern]]> <![CDATA[Will There Be Further R&D Cuts From Pfizer?]]> <![CDATA[Three New Picks from the Hot Biotech IPO Market: Ran Nussbaum]]> <![CDATA[81 Stocks With A Growing Dividend | 28 High-Yield Dividend Growers]]> <![CDATA[This Star Pharma Company Delivers the Goods Once Again]]> <![CDATA[Johnson & Johnson Continues to Maintain Its Leadership Position in the Healthcare Industry]]> <![CDATA[Astex Pharmaceuticals Could See Significant Short And Long Term Price Appreciation]]> <![CDATA[19 Foreign Stocks With Cheap Valuation And Good Yields]]> <![CDATA[Bristol-Myers Squibb’s New Drugs Can Help Reverse Its Sinking Revenue]]> <![CDATA[Brystol-Myers Squibbs Preview: Performance Of New Drugs The Key]]> <![CDATA[Boston Scientific: A Look At The Peripheral Intervention Business]]> <![CDATA[Roche Earnings Preview: What We Are Watching]]> <![CDATA[100 Guru Stock Buy List | The Most Bought Stocks]]> <![CDATA[Warren Buffett’s Best Yielding Dividend Stocks]]> <![CDATA[Baidu Is Cheap But Faces Headwinds From Slowing Search Advertising Growth In China]]> <![CDATA[10 Best Dividend Paying Drug Manufacturing Stocks]]> <![CDATA[Here’s What Matters For Baidu’s $115 Valuation]]> <![CDATA[Heinz Savors Emerging Markets Growth And Reaffirms Brand Strength]]> <![CDATA[Pozen: An Undervalued Investment And Catalyst Trade Opportunity]]> <![CDATA[Bristol-Myers’ Sales Fall On Plavix Patent Cliff But Outlook Is Stable]]> <![CDATA[Plavix Patent Cliff Will Impact Bristol-Myers’ Earnings]]> <![CDATA[The 3 Best Yielding Top Stocks From Ken Fisher’s Q3/2012 Fund Portfolio]]> <![CDATA[Zacks Analyst Jason Napodano’s Seven Biotech Picks Will Keep Your Profits on Solid Ground]]> <![CDATA[Warren Buffett’s Best Yielding Dividend Stocks]]> <![CDATA[Friday’s Small Cap BioPharma Catalyst Trade And Speculation Investment List]]> <![CDATA[Applying the Venture Capital Model to Public Companies: Hugh Cleland]]> <![CDATA[Bristol-Myers’ Eliquis To Exploit The NVAF Market Post Approval In The EU]]> <![CDATA[Wednesday’s Bio-Pharma Catalyst Trades And Watch List]]> <![CDATA[Bristol-Myers Bolsters Portfolio With EU Approval For New Kind Of Diabetes Drug]]> <![CDATA[Is There Big Value In Addiction Fighting Pharmas?]]> <![CDATA[Upcoming BioPharma Catalyst Trades to Consider]]> <![CDATA[Boston Scientific Acquires Vessix Vascular To Bolster Peripheral Intervention Business]]> <![CDATA[The 5 Best Stocks With Dividend Growth From Last Week (Oct 29 – Nov 04, 2012)]]> <![CDATA[Why Teva Pharmaceutical Is An Attractive Buying Opportunity]]> <![CDATA[Emerging Market Health Care: Prognosis Profitable]]> <![CDATA[Pfizer’s $26 Value Finds Support With Strong Prevnar Vaccine Outlook]]> <![CDATA[Boston Scientific Acquires BridgePoint Medical To Bolster Interventional Cardiology Business]]> <![CDATA[Three Factors Why Bristol-Myers Is Worth $35]]> <![CDATA[Bristol-Myers Books $1.8 Billion Loss On Discontinuing Development Of Hep-C Drug]]> <![CDATA[ALS Community Gains Hope Amid Neuralstem’s Surprising Success]]> <![CDATA[Abbott’s Next-Generation Stent To Enter Europe After CE Approval]]> <![CDATA[ChromaDex Announces Record Q2 Revenue and Conference Date for September 20]]> <![CDATA[Coverage Launch: $47 Trefis Price Estimate for Roche Holdings]]> <![CDATA[Abbott Plans New Manufacturing Facility To Expand Indian Nutritional Business]]>